Report Thumbnail
Product Code LP0912615527RS
Published Date 2026/6/8
English125 PagesGlobal

Global Wearable Dosimetry Market Growth 2026-2032 ‐ MedicalDevice / MedTech Market


Report Thumbnail
Product Code LP0912615527RS◆An updated version may be available. We will check for you.
Published Date 2026/6/8
English 125 PagesGlobal

Global Wearable Dosimetry Market Growth 2026-2032 ‐ MedicalDevice / MedTech Market



Abstract

This report provides a comprehensive analysis of the global wearable dosimetry market, which focuses on portable devices for real-time ionizing radiation monitoring. The study examines market dynamics, including key drivers and trends across various sectors such as medical, industrial, and oil and gas applications. By segmenting the industry by product type and geography, the report evaluates the competitive landscape among major players and identifies emerging growth opportunities through 2032.

Related Questions

US$ 2361 million in 2025 and US$ 3528 million in 2032

6.0% (2026 to 2032)

Honeywell, Fisher Scientific, Landauer, Mirion Technologies, Fuji Electric Corporation of America, Polimaster, JP Laboratories, Ludlum Measurements, Laurus Systems, Far West Technology, S.E. International


Summary

Market Overview

The global Wearable Dosimetry market size is predicted to grow from US$ 2361 million in 2025 to US$ 3528 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032.

Definition and Functionality

Wearable dosimetry refers to the use of portable devices designed to monitor and measure an individual’s exposure to ionizing radiation in real-time. These devices are typically worn on the body, allowing continuous monitoring of radiation levels in environments where there is a risk of exposure, such as in medical, nuclear, and industrial settings. By providing immediate feedback, wearable dosimeters help ensure that exposure remains within safe limits, aiding in the protection of workers and patients. The data collected can also be used for regulatory compliance, health monitoring, and research, making wearable dosimetry a critical tool in radiation safety management.

Regional Market Analysis

  • United States: The market for Wearable Dosimetry in the United States is estimated to experience growth from 2025 through 2032.
  • China: The market for Wearable Dosimetry in China is estimated to experience growth from 2025 through 2032.
  • Europe: The market for Wearable Dosimetry in Europe is estimated to experience growth from 2025 through 2032.

Market Segmentation

By Type

  • Personal Electronic Dosimeter
  • Self-reading Dosimeters
  • Processed Dosimeters

By Application

  • Industrial
  • Medical
  • Oil and Gas
  • Other

By Region

  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

Competitive Landscape

Key Players

The global key Wearable Dosimetry players include:

  • Honeywell
  • Fisher Scientific
  • Landauer
  • Mirion Technologies
  • Fuji Electric Corporation of America
  • Polimaster
  • JP Laboratories
  • Ludlum Measurements
  • Laurus Systems
  • Far West Technology
  • S.E. International

Market Share Note: In terms of revenue, the global two largest companies occupied a significant portion of the market share in 2025.

About the Report

Produced by LP Information, Inc. (LPI), the “Wearable Dosimetry Industry Forecast” examines past sales and reviews total world Wearable Dosimetry sales in 2025. It provides a comprehensive analysis by region and market sector of projected Wearable Dosimetry sales for 2026 through 2032. With Wearable Dosimetry sales broken down by region, market sector, and sub-sector, this report provides a detailed analysis in US$ millions of the world Wearable Dosimetry industry.

This Insight Report provides a comprehensive analysis of the global Wearable Dosimetry landscape and highlights key trends related to:

  • Product segmentation
  • Company formation
  • Revenue and market share
  • Latest developments
  • M&A activity

Furthermore, the report analyzes the strategies of leading global companies, focusing on Wearable Dosimetry portfolios and capabilities, market entry strategies, market positions, and geographic footprints to better understand their unique positions in an accelerating global market.

Methodology and Scope

The report evaluates key market trends, drivers, and affecting factors shaping the global outlook for Wearable Dosimetry. It breaks down the forecast by Type, Application, geography, and market size to highlight emerging pockets of opportunity. Utilizing a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study offers a highly nuanced view of the current state and future trajectory of the global Wearable Dosimetry market. It presents a comprehensive overview, market shares, and growth opportunities by product type, application, key manufacturers, and key regions and countries.

Company Profiling Criteria

The profiled companies were selected based on inputs gathered from primary experts and an analysis of the company's coverage, product portfolio, and market penetration.

Key Questions Addressed

  • What is the 10-year outlook for the global Wearable Dosimetry market?
  • What factors are driving Wearable Dosimetry market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Wearable Dosimetry market opportunities vary by end market size?
  • How does Wearable Dosimetry break out by Type and by Application?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Wearable Dosimetry Annual Sales 2021-2032
      • 2.1.2 World Current & Future Analysis for Wearable Dosimetry by Geographic Region, 2021, 2025 & 2032
      • 2.1.3 World Current & Future Analysis for Wearable Dosimetry by Country/Region, 2021, 2025 & 2032
    • 2.2 Wearable Dosimetry Segment by Type
      • 2.2.1 Personal Electronic Dosimeter
      • 2.2.2 Self-reading Dosimeters
      • 2.2.3 Processed Dosimeters
      • 2.2.4 Wearable Dosimetry Sales by Type
        • 2.2.4.1 Global Wearable Dosimetry Sales Market Share by Type (2021-2026)
        • 2.2.4.2 Global Wearable Dosimetry Revenue and Market Share by Type (2021-2026)
        • 2.2.4.3 Global Wearable Dosimetry Sale Price by Type (2021-2026)
    • 2.3 Wearable Dosimetry Segment by Application
      • 2.3.1 Industrial
      • 2.3.2 Medical
      • 2.3.3 Oil and Gas
      • 2.3.4 Other
      • 2.3.5 Wearable Dosimetry Sales by Application
        • 2.3.5.1 Global Wearable Dosimetry Sale Market Share by Application (2021-2026)
        • 2.3.5.2 Global Wearable Dosimetry Revenue and Market Share by Application (2021-2026)
        • 2.3.5.3 Global Wearable Dosimetry Sale Price by Application (2021-2026)
  • 3 Global by Company

    • 3.1 Global Wearable Dosimetry Breakdown Data by Company
      • 3.1.1 Global Wearable Dosimetry Annual Sales by Company (2021-2026)
      • 3.1.2 Global Wearable Dosimetry Sales Market Share by Company (2021-2026)
    • 3.2 Global Wearable Dosimetry Annual Revenue by Company (2021-2026)
      • 3.2.1 Global Wearable Dosimetry Revenue by Company (2021-2026)
      • 3.2.2 Global Wearable Dosimetry Revenue Market Share by Company (2021-2026)
    • 3.3 Global Wearable Dosimetry Sale Price by Company
    • 3.4 Key Manufacturers Wearable Dosimetry Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Wearable Dosimetry Product Location Distribution
      • 3.4.2 Players Wearable Dosimetry Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    • 3.6 New Products and Potential Entrants
    • 3.7 Market M&A Activity & Strategy
  • 4 World Historic Review for Wearable Dosimetry by Geographic Region

    • 4.1 World Historic Wearable Dosimetry Market Size by Geographic Region (2021-2026)
      • 4.1.1 Global Wearable Dosimetry Annual Sales by Geographic Region (2021-2026)
      • 4.1.2 Global Wearable Dosimetry Annual Revenue by Geographic Region (2021-2026)
    • 4.2 World Historic Wearable Dosimetry Market Size by Country/Region (2021-2026)
      • 4.2.1 Global Wearable Dosimetry Annual Sales by Country/Region (2021-2026)
      • 4.2.2 Global Wearable Dosimetry Annual Revenue by Country/Region (2021-2026)
    • 4.3 Americas Wearable Dosimetry Sales Growth
    • 4.4 APAC Wearable Dosimetry Sales Growth
    • 4.5 Europe Wearable Dosimetry Sales Growth
    • 4.6 Middle East & Africa Wearable Dosimetry Sales Growth
  • 5 Americas

    • 5.1 Americas Wearable Dosimetry Sales by Country
      • 5.1.1 Americas Wearable Dosimetry Sales by Country (2021-2026)
      • 5.1.2 Americas Wearable Dosimetry Revenue by Country (2021-2026)
    • 5.2 Americas Wearable Dosimetry Sales by Type (2021-2026)
    • 5.3 Americas Wearable Dosimetry Sales by Application (2021-2026)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Wearable Dosimetry Sales by Region
      • 6.1.1 APAC Wearable Dosimetry Sales by Region (2021-2026)
      • 6.1.2 APAC Wearable Dosimetry Revenue by Region (2021-2026)
    • 6.2 APAC Wearable Dosimetry Sales by Type (2021-2026)
    • 6.3 APAC Wearable Dosimetry Sales by Application (2021-2026)
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Wearable Dosimetry by Country
      • 7.1.1 Europe Wearable Dosimetry Sales by Country (2021-2026)
      • 7.1.2 Europe Wearable Dosimetry Revenue by Country (2021-2026)
    • 7.2 Europe Wearable Dosimetry Sales by Type (2021-2026)
    • 7.3 Europe Wearable Dosimetry Sales by Application (2021-2026)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Wearable Dosimetry by Country
      • 8.1.1 Middle East & Africa Wearable Dosimetry Sales by Country (2021-2026)
      • 8.1.2 Middle East & Africa Wearable Dosimetry Revenue by Country (2021-2026)
    • 8.2 Middle East & Africa Wearable Dosimetry Sales by Type (2021-2026)
    • 8.3 Middle East & Africa Wearable Dosimetry Sales by Application (2021-2026)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Wearable Dosimetry
    • 10.3 Manufacturing Process Analysis of Wearable Dosimetry
    • 10.4 Industry Chain Structure of Wearable Dosimetry
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Wearable Dosimetry Distributors
    • 11.3 Wearable Dosimetry Customer
  • 12 World Forecast Review for Wearable Dosimetry by Geographic Region

    • 12.1 Global Wearable Dosimetry Market Size Forecast by Region
      • 12.1.1 Global Wearable Dosimetry Forecast by Region (2027-2032)
      • 12.1.2 Global Wearable Dosimetry Annual Revenue Forecast by Region (2027-2032)
    • 12.2 Americas Forecast by Country (2027-2032)
    • 12.3 APAC Forecast by Region (2027-2032)
    • 12.4 Europe Forecast by Country (2027-2032)
    • 12.5 Middle East & Africa Forecast by Country (2027-2032)
    • 12.6 Global Wearable Dosimetry Forecast by Type (2027-2032)
    • 12.7 Global Wearable Dosimetry Forecast by Application (2027-2032)
  • 13 Key Players Analysis

    • 13.1 Honeywell
      • 13.1.1 Honeywell Company Information
      • 13.1.2 Honeywell Wearable Dosimetry Product Portfolios and Specifications
      • 13.1.3 Honeywell Wearable Dosimetry Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.1.4 Honeywell Main Business Overview
      • 13.1.5 Honeywell Latest Developments
    • 13.2 Fisher Scientific
      • 13.2.1 Fisher Scientific Company Information
      • 13.2.2 Fisher Scientific Wearable Dosimetry Product Portfolios and Specifications
      • 13.2.3 Fisher Scientific Wearable Dosimetry Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.2.4 Fisher Scientific Main Business Overview
      • 13.2.5 Fisher Scientific Latest Developments
    • 13.3 Landauer
      • 13.3.1 Landauer Company Information
      • 13.3.2 Landauer Wearable Dosimetry Product Portfolios and Specifications
      • 13.3.3 Landauer Wearable Dosimetry Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.3.4 Landauer Main Business Overview
      • 13.3.5 Landauer Latest Developments
    • 13.4 Mirion Technologies
      • 13.4.1 Mirion Technologies Company Information
      • 13.4.2 Mirion Technologies Wearable Dosimetry Product Portfolios and Specifications
      • 13.4.3 Mirion Technologies Wearable Dosimetry Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.4.4 Mirion Technologies Main Business Overview
      • 13.4.5 Mirion Technologies Latest Developments
    • 13.5 Fuji Electric Corporation of America
      • 13.5.1 Fuji Electric Corporation of America Company Information
      • 13.5.2 Fuji Electric Corporation of America Wearable Dosimetry Product Portfolios and Specifications
      • 13.5.3 Fuji Electric Corporation of America Wearable Dosimetry Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.5.4 Fuji Electric Corporation of America Main Business Overview
      • 13.5.5 Fuji Electric Corporation of America Latest Developments
    • 13.6 Polimaster
      • 13.6.1 Polimaster Company Information
      • 13.6.2 Polimaster Wearable Dosimetry Product Portfolios and Specifications
      • 13.6.3 Polimaster Wearable Dosimetry Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.6.4 Polimaster Main Business Overview
      • 13.6.5 Polimaster Latest Developments
    • 13.7 JP Laboratories
      • 13.7.1 JP Laboratories Company Information
      • 13.7.2 JP Laboratories Wearable Dosimetry Product Portfolios and Specifications
      • 13.7.3 JP Laboratories Wearable Dosimetry Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.7.4 JP Laboratories Main Business Overview
      • 13.7.5 JP Laboratories Latest Developments
    • 13.8 Ludlum Measurements
      • 13.8.1 Ludlum Measurements Company Information
      • 13.8.2 Ludlum Measurements Wearable Dosimetry Product Portfolios and Specifications
      • 13.8.3 Ludlum Measurements Wearable Dosimetry Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.8.4 Ludlum Measurements Main Business Overview
      • 13.8.5 Ludlum Measurements Latest Developments
    • 13.9 Laurus Systems
      • 13.9.1 Laurus Systems Company Information
      • 13.9.2 Laurus Systems Wearable Dosimetry Product Portfolios and Specifications
      • 13.9.3 Laurus Systems Wearable Dosimetry Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.9.4 Laurus Systems Main Business Overview
      • 13.9.5 Laurus Systems Latest Developments
    • 13.10 Far West Technology
      • 13.10.1 Far West Technology Company Information
      • 13.10.2 Far West Technology Wearable Dosimetry Product Portfolios and Specifications
      • 13.10.3 Far West Technology Wearable Dosimetry Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.10.4 Far West Technology Main Business Overview
      • 13.10.5 Far West Technology Latest Developments
    • 13.11 S.E. International
      • 13.11.1 S.E. International Company Information
      • 13.11.2 S.E. International Wearable Dosimetry Product Portfolios and Specifications
      • 13.11.3 S.E. International Wearable Dosimetry Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.11.4 S.E. International Main Business Overview
      • 13.11.5 S.E. International Latest Developments
  • 14 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.